|
US20070021493A1
(en)
|
1999-09-16 |
2007-01-25 |
Curis, Inc. |
Mediators of hedgehog signaling pathways, compositions and uses related thereto
|
|
US7230000B1
(en)
|
1999-10-27 |
2007-06-12 |
Cytokinetics, Incorporated |
Methods and compositions utilizing quinazolinones
|
|
US6545004B1
(en)
|
1999-10-27 |
2003-04-08 |
Cytokinetics, Inc. |
Methods and compositions utilizing quinazolinones
|
|
US7671200B2
(en)
*
|
1999-10-27 |
2010-03-02 |
Cytokinetics, Inc. |
Quinazolinone KSP inhibitors
|
|
US8852937B2
(en)
|
2000-03-30 |
2014-10-07 |
Curis, Inc. |
Small organic molecule regulators of cell proliferation
|
|
US7115653B2
(en)
|
2000-03-30 |
2006-10-03 |
Curis, Inc. |
Small organic molecule regulators of cell proliferation
|
|
KR100883184B1
(ko)
|
2000-12-11 |
2009-02-12 |
암젠 인코포레이션 |
Ｃｘｃｒ3 길항제
|
|
US6469002B1
(en)
*
|
2001-04-19 |
2002-10-22 |
Millennium Pharmaceuticals, Inc. |
Imidazolidine compounds
|
|
US6794379B2
(en)
|
2001-06-06 |
2004-09-21 |
Tularik Inc. |
CXCR3 antagonists
|
|
EP1465488A4
(en)
*
|
2001-08-30 |
2007-04-18 |
Chemocentryx Inc |
ARYLAMINES AS INHIBITORS OF THE BINDING OF CHEMOKINE A US28
|
|
DE60236605D1
(de)
|
2001-09-05 |
2010-07-15 |
Minerva Biotechnologies Corp |
Zusammensetzungen und deren verwendung zur behandlung von krebs
|
|
US6753428B2
(en)
*
|
2001-11-20 |
2004-06-22 |
Cytokinetics, Inc. |
Process for the racemization of chiral quinazolinones
|
|
CA2475879A1
(en)
*
|
2002-02-15 |
2003-08-28 |
Cytokinetics, Inc. |
Synthesis of quinazolinones
|
|
ES2361403T3
(es)
*
|
2002-03-07 |
2011-06-16 |
X-Ceptor Therapeutics, Inc. |
Moduladores de quinazolinona de receptores nucleares.
|
|
US7381730B2
(en)
*
|
2002-03-15 |
2008-06-03 |
Bristol-Myers Squibb Company |
3-arylquinazoline derivatives as selective estrogen receptor beta modulators
|
|
JPWO2003082335A1
(ja)
*
|
2002-04-03 |
2005-07-28 |
住友製薬株式会社 |
新規血糖調節薬及びそのスクリーニング方法
|
|
EP1513534A2
(en)
*
|
2002-04-04 |
2005-03-16 |
Cv Therapeutics, Inc. |
Compounds for increasing abca-1 expression useful for treating coronary artery disease and atherosclerosis
|
|
US20030225288A1
(en)
*
|
2002-04-12 |
2003-12-04 |
Millennium Pharmaceuticals, Inc. |
Imidazolidine compounds
|
|
PL211300B1
(pl)
*
|
2002-04-17 |
2012-05-31 |
Cytokinetics Inc |
Związek i kompozycja zawierająca ten związek
|
|
AU2003270015A1
(en)
|
2002-05-09 |
2003-12-02 |
Cytokinetics, Inc. |
Compounds, compositions, and methods
|
|
WO2003094839A2
(en)
*
|
2002-05-09 |
2003-11-20 |
Cytokinetics, Inc. |
Pyrimidinone compounds, compositions and methods
|
|
EP1513820A4
(en)
|
2002-05-23 |
2006-09-13 |
Cytokinetics Inc |
COMPOUNDS, COMPOSITIONS AND METHODS
|
|
EP2402310A1
(en)
*
|
2002-05-24 |
2012-01-04 |
Millennium Pharmaceuticals, Inc. |
CCR9 inhibitors and methods of use thereof
|
|
AU2003236527A1
(en)
*
|
2002-06-14 |
2003-12-31 |
Cytokinetics, Inc. |
Compounds, compositions, and methods
|
|
EP1539727B1
(en)
*
|
2002-07-17 |
2009-02-18 |
Cytokinetics, Inc. |
Compounds, compositions, and methods for treating cellular proliferative diseases
|
|
EP1537089A4
(en)
|
2002-07-23 |
2008-04-16 |
Cytokinetics Inc |
CONNECTIONS, COMPOSITIONS AND PROCEDURES
|
|
EP1539180A4
(en)
*
|
2002-08-21 |
2006-08-30 |
Cytokinetics Inc |
COMPOUNDS, COMPOSITIONS AND METHODS
|
|
JP2005539062A
(ja)
*
|
2002-09-13 |
2005-12-22 |
サイトキネティクス・インコーポレーテッド |
化合物、組成物および方法
|
|
AU2003277079A1
(en)
|
2002-09-30 |
2004-05-04 |
Cytokinetics, Inc. |
Compounds, compositions, and methods
|
|
EP1558585B1
(en)
*
|
2002-10-04 |
2013-09-25 |
Prana Biotechnology Limited |
Neurologically-active compounds
|
|
KR20050122220A
(ko)
*
|
2003-03-25 |
2005-12-28 |
다케다 샌디에고, 인코포레이티드 |
디펩티딜 펩티다제 억제제
|
|
WO2004092123A2
(en)
*
|
2003-04-10 |
2004-10-28 |
Microbia, Inc. |
Inhibitors of fungal invasion
|
|
US20050165089A1
(en)
*
|
2003-10-06 |
2005-07-28 |
Gustave Bergnes |
Compounds, compositions and methods
|
|
WO2005041888A2
(en)
*
|
2003-11-03 |
2005-05-12 |
Cytokinetics, Inc. |
Pyrimidin-4-one compounds, compositions and methods
|
|
JP2007510660A
(ja)
*
|
2003-11-07 |
2007-04-26 |
サイトキネティクス・インコーポレーテッド |
化合物、組成物及び方法
|
|
US7439254B2
(en)
|
2003-12-08 |
2008-10-21 |
Cytokinetics, Inc. |
Compounds, compositions, and methods
|
|
JP4452839B2
(ja)
*
|
2004-03-09 |
2010-04-21 |
国立大学法人京都大学 |
Ｃｘｃｒ３阻害剤を含有する医薬組成物
|
|
MXPA06011236A
(es)
|
2004-04-02 |
2007-01-16 |
Prana Biotechnology Ltd |
Compuestos neurologicamente activos.
|
|
US7375102B2
(en)
*
|
2004-06-28 |
2008-05-20 |
Amgen Sf, Llc |
Tetrahydroquinazolin-4(3H)-one-related and tetrahydropyrido[2,3-D]pyrimidin-4(3H)-one-related compounds, compositions and methods for their use
|
|
US7939538B2
(en)
*
|
2004-06-28 |
2011-05-10 |
Amgen Inc. |
Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseases
|
|
US7271271B2
(en)
|
2004-06-28 |
2007-09-18 |
Amgen Sf, Llc |
Imidazolo-related compounds, compositions and methods for their use
|
|
US20070207996A1
(en)
*
|
2004-08-30 |
2007-09-06 |
Auger Kurt R |
Novel Compositions And Methods Of Treatment
|
|
PE20060598A1
(es)
|
2004-09-13 |
2006-08-21 |
Ono Pharmaceutical Co |
Derivado heterociclo conteniendo nitrogeno como antagonista de quimiocina ccr5
|
|
JP2008514709A
(ja)
*
|
2004-10-01 |
2008-05-08 |
メルク エンド カムパニー インコーポレーテッド |
眼科疾患を治療するための組成物および方法
|
|
EP1831225A2
(en)
|
2004-11-19 |
2007-09-12 |
The Regents of the University of California |
Anti-inflammatory pyrazolopyrimidines
|
|
US20110052612A1
(en)
|
2005-05-31 |
2011-03-03 |
Ono Pharmaceutical Co., Ltd. |
Spiropiperidine compound and medicinal use thereof
|
|
MX2007016270A
(es)
|
2005-06-27 |
2008-03-05 |
Amgen Inc |
Compuestos aril nitrilo anti-inflamatorios.
|
|
EP1940407B1
(en)
*
|
2005-09-26 |
2010-11-10 |
Merck Sharp & Dohme Corp. |
N-(4-oxo-3,4-dihydroquinazolin-2-yl)butanamides as androgen receptor modulators
|
|
KR20090008217A
(ko)
|
2006-03-10 |
2009-01-21 |
오노 야꾸힝 고교 가부시키가이샤 |
질소 함유 복소환 유도체 및 이들을 유효 성분으로 하는 약제
|
|
KR20150038395A
(ko)
|
2006-04-04 |
2015-04-08 |
더 리젠트스 오브 더 유니이버시티 오브 캘리포니아 |
키나제 길항물질
|
|
ES2437997T3
(es)
|
2006-04-14 |
2014-01-15 |
Prana Biotechnology Limited |
Método de tratamiento de la degeneración macular relacionada con la edad (AMD)
|
|
US20090325992A1
(en)
|
2006-07-31 |
2009-12-31 |
Ono Pharmaceutical Co., Ltd. |
Compound having cyclic group bound thereto through spiro binding and use thereof
|
|
AU2007281535A1
(en)
*
|
2006-08-01 |
2008-02-07 |
Applied Biosystems, Llc. |
Detection of analytes and nucleic acids
|
|
EP2079739A2
(en)
*
|
2006-10-04 |
2009-07-22 |
Pfizer Products Inc. |
Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists
|
|
US8273747B2
(en)
|
2006-11-02 |
2012-09-25 |
Curis, Inc. |
Small organic molecule regulators of cell proliferation
|
|
WO2008085828A2
(en)
|
2007-01-03 |
2008-07-17 |
The Johns Hopkins University |
Peptide modulators of angiogenesis and use thereof
|
|
WO2009046448A1
(en)
|
2007-10-04 |
2009-04-09 |
Intellikine, Inc. |
Chemical entities and therapeutic uses thereof
|
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
|
KR101653842B1
(ko)
|
2008-01-04 |
2016-09-02 |
인텔리카인, 엘엘씨 |
특정 화학 물질, 조성물 및 방법
|
|
WO2009114870A2
(en)
|
2008-03-14 |
2009-09-17 |
Intellikine, Inc. |
Kinase inhibitors and methods of use
|
|
WO2009114874A2
(en)
|
2008-03-14 |
2009-09-17 |
Intellikine, Inc. |
Benzothiazole kinase inhibitors and methods of use
|
|
JP5788316B2
(ja)
|
2008-07-08 |
2015-09-30 |
インテリカイン， エルエルシー |
キナーゼインヒビターおよび使用方法
|
|
US20110224223A1
(en)
|
2008-07-08 |
2011-09-15 |
The Regents Of The University Of California, A California Corporation |
MTOR Modulators and Uses Thereof
|
|
CA2738429C
(en)
|
2008-09-26 |
2016-10-25 |
Intellikine, Inc. |
Heterocyclic kinase inhibitors
|
|
WO2010045542A2
(en)
|
2008-10-16 |
2010-04-22 |
The Regents Of The University Of California |
Fused ring heteroaryl kinase inhibitors
|
|
US8476282B2
(en)
|
2008-11-03 |
2013-07-02 |
Intellikine Llc |
Benzoxazole kinase inhibitors and methods of use
|
|
WO2010129351A1
(en)
|
2009-04-28 |
2010-11-11 |
Schepens Eye Research Institute |
Method to identify and treat age-related macular degeneration
|
|
CA2760791C
(en)
|
2009-05-07 |
2017-06-20 |
Intellikine, Inc. |
Heterocyclic compounds and uses thereof
|
|
US8980899B2
(en)
|
2009-10-16 |
2015-03-17 |
The Regents Of The University Of California |
Methods of inhibiting Ire1
|
|
JP5951600B2
(ja)
|
2010-05-21 |
2016-07-13 |
インフィニティー ファーマシューティカルズ， インコーポレイテッド |
キナーゼ調節のための、化合物、組成物および方法
|
|
CN103298474B
(zh)
|
2010-11-10 |
2016-06-29 |
无限药品股份有限公司 |
杂环化合物及其用途
|
|
AR084824A1
(es)
|
2011-01-10 |
2013-06-26 |
Intellikine Inc |
Procesos para preparar isoquinolinonas y formas solidas de isoquinolinonas
|
|
TWI592411B
(zh)
|
2011-02-23 |
2017-07-21 |
英特爾立秦有限責任公司 |
激酶抑制劑之組合及其用途
|
|
AU2012284088B2
(en)
|
2011-07-19 |
2015-10-08 |
Infinity Pharmaceuticals Inc. |
Heterocyclic compounds and uses thereof
|
|
MX2014000648A
(es)
|
2011-07-19 |
2014-09-25 |
Infinity Pharmaceuticals Inc |
Compuestos heterociclicos y sus usos.
|
|
US8785470B2
(en)
|
2011-08-29 |
2014-07-22 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
CA2846496C
(en)
|
2011-09-02 |
2020-07-14 |
The Regents Of The University Of California |
Substituted pyrazolo[3,4-d]pyrimidines and uses thereof
|
|
US8940742B2
(en)
|
2012-04-10 |
2015-01-27 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
US8828998B2
(en)
|
2012-06-25 |
2014-09-09 |
Infinity Pharmaceuticals, Inc. |
Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
|
|
MX2015003874A
(es)
|
2012-09-26 |
2015-12-16 |
Univ California |
Modulacion de ire1.
|
|
WO2014071109A1
(en)
|
2012-11-01 |
2014-05-08 |
Infinity Pharmaceuticals, Inc. |
Treatment of cancers using pi3 kinase isoform modulators
|
|
US9481667B2
(en)
|
2013-03-15 |
2016-11-01 |
Infinity Pharmaceuticals, Inc. |
Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
|
|
PE20160685A1
(es)
|
2013-10-04 |
2016-07-23 |
Infinity Pharmaceuticals Inc |
Compuestos heterociclicos y usos de los mismos
|
|
WO2015051241A1
(en)
|
2013-10-04 |
2015-04-09 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
CN113620958A
(zh)
|
2014-03-19 |
2021-11-09 |
无限药品股份有限公司 |
用于治疗PI3K-γ介导的障碍的杂环化合物
|
|
AR099789A1
(es)
*
|
2014-03-24 |
2016-08-17 |
Actelion Pharmaceuticals Ltd |
Derivados de 8-(piperazin-1-il)-1,2,3,4-tetrahidro-isoquinolina
|
|
WO2015160975A2
(en)
|
2014-04-16 |
2015-10-22 |
Infinity Pharmaceuticals, Inc. |
Combination therapies
|
|
US9708348B2
(en)
|
2014-10-03 |
2017-07-18 |
Infinity Pharmaceuticals, Inc. |
Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof
|
|
PH12018500554B1
(en)
|
2015-09-14 |
2024-01-24 |
Infinity Pharmaceuticals Inc |
Solid forms of isoquinolinone derivatives, process of making, compositions comprising, and methods of using the same
|
|
WO2017161116A1
(en)
|
2016-03-17 |
2017-09-21 |
Infinity Pharmaceuticals, Inc. |
Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors
|
|
WO2017214269A1
(en)
|
2016-06-08 |
2017-12-14 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
RU2754507C2
(ru)
|
2016-06-24 |
2021-09-02 |
Инфинити Фармасьютикалз, Инк. |
Комбинированная терапия
|
|
WO2022014433A1
(ja)
*
|
2020-07-13 |
2022-01-20 |
国立大学法人富山大学 |
Ｎｒ４ａ１拮抗薬を用いた鎮痛薬
|
|
US20230321063A1
(en)
*
|
2020-08-20 |
2023-10-12 |
Seattle Children's Hospital D/B/A Seattle Children's Research Institute |
Compositions and methods to reduce neuroinflammation
|